Audentes Therapeutics, Inc. Operating Income
Audentes Therapeutics, Inc. reported Operating Income of -$47.83 million for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2019-11-07
- Audentes Therapeutics, Inc. operating income (loss) for the quarter ending 2019-09-30 was -$47.83M.
- Audentes Therapeutics, Inc. operating income (loss) for the quarter ending 2019-06-30 was -$47.08M.
- Audentes Therapeutics, Inc. operating income (loss) for the quarter ending 2019-03-31 was -$51.83M.
- Audentes Therapeutics, Inc. operating income (loss) for the quarter ending 2018-12-31 was -$37.60M.
- Audentes Therapeutics, Inc. operating income (loss) for fiscal 2018 was -$134.37M.
- Audentes Therapeutics, Inc. operating income (loss) for fiscal 2017 was -$93.18M.
- Audentes Therapeutics, Inc. operating income (loss) for fiscal 2016 was -$60.05M.
- Audentes Therapeutics, Inc. operating income (loss) for fiscal 2015 was -$26.73M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|
| 2019-09-30 | -$47.83M 10-Q · filed 2019-11-07 | -$94.90M derived: sum of 2 quarters · filed 2019-11-07 | -$146.73M 10-Q · filed 2019-11-07 | -$184.33M derived: sum of 4 quarters · filed 2019-11-07 | |
| 2019-06-30 | -$47.08M 10-Q · filed 2019-08-07 | -$98.91M 10-Q · filed 2019-08-07 | -$136.50M derived: sum of 3 quarters · filed 2019-08-07 | -$174.24M derived: sum of 4 quarters · filed 2019-11-07 | |
| 2019-03-31 | -$51.83M 10-Q · filed 2019-05-08 | -$89.43M derived: sum of 2 quarters · filed 2019-05-08 | -$127.16M derived: sum of 3 quarters · filed 2019-11-07 | -$159.79M derived: sum of 4 quarters · filed 2019-11-07 | |
| 2018-12-31 | -$37.60M 10-K · filed 2019-03-01 | -$75.33M derived: sum of 2 quarters · filed 2019-11-07 | -$107.96M derived: sum of 3 quarters · filed 2019-11-07 | -$134.37M 10-K · filed 2019-03-01 | |
| 2018-09-30 | -$37.73M 10-Q · filed 2019-11-07 | -$70.36M derived: sum of 2 quarters · filed 2019-11-07 | -$96.77M 10-Q · filed 2019-11-07 | -$123.66M derived: sum of 4 quarters · filed 2019-11-07 | |
| 2018-06-30 | -$32.63M 10-Q · filed 2019-08-07 | -$59.04M 10-Q · filed 2019-08-07 | -$85.92M derived: sum of 3 quarters · filed 2019-08-07 | -$111.13M derived: sum of 4 quarters · filed 2019-08-07 | |
| 2018-03-31 | -$26.41M 10-Q · filed 2019-05-08 | -$53.29M derived: sum of 2 quarters · filed 2019-05-08 | -$78.50M derived: sum of 3 quarters · filed 2019-05-08 | -$101.34M derived: sum of 4 quarters · filed 2019-05-08 | |
| 2017-12-31 | -$26.88M 10-K · filed 2019-03-01 | -$52.09M derived: sum of 2 quarters · filed 2019-03-01 | -$74.93M derived: sum of 3 quarters · filed 2019-03-01 | -$93.18M 10-K · filed 2019-03-01 | |
| 2017-09-30 | -$25.21M 10-K · filed 2019-03-01 | -$48.05M derived: sum of 2 quarters · filed 2019-03-01 | -$66.30M 10-Q · filed 2018-11-07 | -$86.13M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-06-30 | -$22.84M 10-K · filed 2019-03-01 | -$41.09M 10-Q · filed 2018-08-07 | -$60.92M derived: sum of 3 quarters · filed 2019-03-01 | -$76.39M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-03-31 | -$18.25M 10-K · filed 2019-03-01 | -$38.08M derived: sum of 2 quarters · filed 2019-03-01 | -$53.55M derived: sum of 3 quarters · filed 2019-03-01 | -$67.75M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2016-12-31 | -$19.83M 10-K · filed 2019-03-01 | -$35.30M derived: sum of 2 quarters · filed 2019-03-01 | -$49.51M derived: sum of 3 quarters · filed 2019-03-01 | -$60.05M 10-K · filed 2019-03-01 | |
| 2016-09-30 | -$15.47M 10-K · filed 2019-03-01 | -$29.68M derived: sum of 2 quarters · filed 2019-03-01 | -$40.21M 10-Q · filed 2017-11-14 | -$50.25M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2016-06-30 | -$14.20M 10-K · filed 2019-03-01 | -$14.20M 10-Q · filed 2016-09-01 | -$24.74M 10-Q · filed 2017-08-10 | -$34.77M derived: sum of 3 quarters · filed 2019-03-01 | -$41.77M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-03-31 | -$10.54M 10-K · filed 2019-03-01 | -$20.57M derived: sum of 2 quarters · filed 2019-03-01 | -$27.57M derived: sum of 3 quarters · filed 2019-03-01 | -$33.10M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2015-12-31 | -$10.03M 10-K · filed 2017-03-13 | -$17.03M derived: sum of 2 quarters · filed 2017-03-13 | -$22.56M derived: sum of 3 quarters · filed 2017-03-13 | -$26.73M 10-K · filed 2018-03-09 | |
| 2015-09-30 | -$7.00M 10-K · filed 2017-03-13 | -$12.53M derived: sum of 2 quarters · filed 2017-03-13 | -$16.69M 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | -$5.53M 10-K · filed 2017-03-13 | -$9.70M 10-Q · filed 2016-09-01 | |||
| 2015-03-31 | -$4.16M 10-K · filed 2017-03-13 | ||||
| 2014-12-31 | -$10.95M 10-K · filed 2017-03-13 |